FDA Approves Abbott's HBV MDx Test

The test is the first automated molecular test for assessing HBV treatment to receive FDA approval, Abbott said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories